Karuna Pharmaceuticals raises $42 million in Series A funding round
The company plans to use the financing to support development of its drug, KarXT, in schizophrenia and indications like pain.
antipsychotic drug
The company plans to use the financing to support development of its drug, KarXT, in schizophrenia and indications like pain.